Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 8Filgrastim 4Cyclophosphamide 4Clofarabine 4Radiotherapy 3Idarubicin 3eltrombopag 2Thiotepa 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Imatinib Mesylate 2Genetic Testing 2Gene Expression Profiling 2Etoposide 2Daunorubicin 2Arsenic Trioxide 2Antilymphocyte Serum 2tipifarnib 1temsirolimus 1midostaurin 1fludarabine phosphate 1dexamethasone acetate 1aldesleukin 1Whole-Body Irradiation 1Reverse Transcriptase Polymerase Chain Reaction 1Proto-Oncogene Proteins c-kit 1Mitoxantrone 1Microarray Analysis 1Methoxsalen 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Eosinophilic, Acute × Proto-Oncogene Proteins c-kit × Clear all
NCT00509093 2020-03-17

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡